Legionnaires' disease: A rational approach to therapy

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 5, 2003, Pages 1119-1129

  Roig, Jorge ^a   Rello, Jordi ^b  

^a HOSPITAL NOSTRA SENYORA DE MERITXELL   (Andorra)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Legionnaries' disease; Therapeutic approach

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; BILIRUBIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIRITHROMYCIN; DOXYCYCLINE; EPIGALLOCATECHIN; ERYTHROMYCIN; GAMMA INTERFERON; JOSAMYCIN; LEVOFLOXACIN; LICOCHALCONE A; MACROLIDE; MIDECAMYCIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; CHROMATOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HYPERBILIRUBINEMIA; IMMUNE DEFICIENCY; JAUNDICE; LEGIONELLA; LEGIONNAIRE DISEASE; LUNG BIOPSY; MEDICAL DECISION MAKING; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; REVIEW; RISK FACTOR; SEROLOGY; SHOCK; SPONTANEOUS ABORTION; SPUTUM CULTURE; SUPERINFECTION; TERATOGENICITY; THORACOTOMY; TREATMENT OUTCOME; URINALYSIS; WATER TREATMENT;

ANIMALS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LEGIONELLA; LEGIONNAIRES' DISEASE; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 0038778661     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg191     Document Type: Review

References (114)

1. Roig, J., Rello, J. & Yu, V. L. (2002). Legionnaires' disease: a guide to diagnosis and therapy. Journal of Respiratory Diseases 23, 229-34.
2. Woodhead, M. (2002). Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. European Respiratory Journal 20, Suppl. 36, 20s-7s.
3. Sopena, N., Sabria-Leal, M., Pedro-Botet, M. L., Padilla, E., Domínguez, J., Morera, J. et al. (1998). Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 113, 1195-200.
4. Formica, N., Yates, M., Beers, M., Carnie, J., Hogg, G., Ryan, N. et al. (2001). The impact of diagnosis by Legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease. Epidemiology and Infection 127, 275-80.
5. Fields, B., Benson, R. F. & Besser, R. E. (2002). Legionella and Legionnaires' disease: 25 years of investigation. Clinical Microbiology Reviews 15, 506-26.
6. Muder, R. R. & Yu, V. L. (2002). Infection due to Legionella species other than L. pneumophila. Clinical Infectious Diseases 35, 990-8.
7. Yu, V. L., Plouffe, J. F., Pastoris, M. C., Stout, J. E., Schousboe, M., Widmer, A. et al. (2001). Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. Journal of Infectious Diseases 186, 127-8.
8. McNally, C., Hackman, B., Fields, B. S. & Plouffe, J. F. (2000). Potential importance of Legionella species as etiologies in community acquired pneumonia (CAP). Diagnostic Microbiology and Infectious Disease 38, 79-82.
9. Marrie, T. J., Raoult, D., La Scola, B., Birtles, R. J. & de Carolis, E. (2001). Canadian Community-Acquired Pneumonia Study Group. Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. Emerging Infectious Diseases 7, 1026-9.
10. La Scola, B., Mezi, L., Auffray, J. P., Berland, Y. & Raoult, D. (2002). Patients in the intensive care unit are exposed to amoeba-associated pathogens. Infection Control and Hospital Epidemiology 23, 462-5.
11. Maurin, M., Bryskier, A. & Raoult, D. (2002). Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae. Antimicrobial Agents and Chemotherapy 46, 3065-7.
12. Pedro-Botet, M. L., Stout, J. E. & Yu, V. L. (2002). Legionnaires' disease contracted from patient homes: the coming of the third plague? European Journal of Clinical Microbiology and Infectious Diseases 21, 699-705.
13. Barker, J., Scaife, H. & Brown, M. R. (1995). Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrobial Agents and Chemotherapy 39, 2684-8.
14. Cirillo, J. D., Cirillo, S. L., Yan, L., Bermudez, L. E., Falkow, S. & Tompkins, L. S. (1999). Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila. Infection and Immunity 67, 4427-34.
15. Cirillo, J. D., Falkow, S. & Tompkins, L. S. (1994). Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infection and Immunity 62, 3254-61.
16. Maruta, K., Miyamoto, H., Hamada, T., Ogawa, M., Taniguchi, H. & Yoshida, S. I. (1998). Entry and intracellular growth of Legionella dumofii in alveolar epithelial cells. American Journal of Respiratory and Critical Care Medicine 157, 1967-74.
17. Cianciotto, N. P. (2001). Pathogenicity of Legionella pneumophila. International Journal of Medical Microbiology 29, 331-43.
18. Steinert, M., Hentschel, U. & Hacker, J. (2002). Legionella pneumophila: an aquatic microbe goes astray. FEMS Microbiology Reviews 26, 149-62.
19. Matsunaga, K., Klein, T. W., Friedman, H. & Yamamoto, Y. (2002). In vitro therapeutic effect of epigallocatechin gallate on nicotine-induced impairment of resistance to Legionella pneumophila infection of established MH-S alveolar macrophages. Journal of Infectious Diseases 185, 229-36.
20. 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptors β2 responses to Legionella pneumophila infection. Journal of Immunology 164, 6461-6.
21. Singh, N., Gayowski, T., Wagener, M., Marino, I. R. & Yu, V. L. (1996). Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. Transplantation 61, 396-401.
22. Neumann, U. P., Langrehr, J. M., Kaisers, U., Lang, M., Schmitz, V. & Neuhaus, P. (2002). Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transplant international 15, 226-32.
23. Falguera, M., Sacristán, O., Nogués, A., Ruiz-González, A., Gracía, M., Mononelles, A. et al. (2001 . Nonsevere community-acquired pneumonia. Correlation between cause and severity or comorbidity. Archives of Internal Medicine 161, 1866-72.
24. Roig, J., Aguilar, X., Ruiz, J., Domingo, C., Mesalles, E., Manterola, J. et al. (1991). Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias. Chest 99, 344-50.
25. Vikram, H. R. & Bia, F. J. (2002). Severe Legionella pneumophila pneumonia in a patient with iron overload. Scandinavian Journal of Infectious Diseases 34, 772-4.
26. Spieker, S., Petersen, D., Rolfs, A., Fehrenbach, F., Kuntz, R., Seuffer, R. H. et al. (1998). Acute disseminated encephalomyelitis following Pontiac fever. European Neurology 40, 169-72.
27. Gupta, S. K., Imperiale, T. F. & Sarosi, G. A. (2001). Evaluation of the Winthrop University Hospital criteria to identify Legionella pneumonia. Chest 120, 1064-71.
28. Roig, J., Martínez-Benazet, J. & Salvador, J. (1998). Radiologic features of legionellosis. Current Topics in Radiology 1, 101 -6.
29. Domingo, C., Roig, J., Planas, F., Bechini, J., Tenesa, M. & Morera, J. (1991). Radiographic appearance of nosocomial legionnaire's disease after erythromycin treatment. Thorax 46, 663-6.
30. Yzerman, E. P., den Boer, J. W., Lettinga, K. D., Schellekens, J., Dankert, J. & Peeters, M. (2002). Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in the Netherlands. Journal of Clinical Microbiology 40, 3232-6.
31. Deforges, L., Legrand, P., Tankovic, J., Brun-Buisson, C., Lang, P. & Soussy, C. J. (1999). Case of false-positive results of the urinary antigen test for Legionella pneumophila. Clinical Infectious Diseases 29, 953-4.
32. Marston, B. J., Lipman, H. B. & Breiman, R. F. (1994). Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Archives of Internal Medicine 154, 2417-22.
33. Heath, C. H., Grove, D. I. & Looke, D. F. (1996). Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. European Journal of Clinical Microbiology and Infectious Diseases 15, 286-90.
34. El-Ebiary, M., Sarmiento, X., Torres, A., Nogue, S., Mesalles, E., Bodi, M. et al. (1997). Prognostic factors of severe Legionella pneumonia requiring admission to ICU. American Journal of Respiratory and Critical Care Medicine 156, 1467-72.
35. Tkatch, L. S., Kusne, S., Irish, W. D., Krystofiak, S. & Wing, E. (1998). Epidemiology of Legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clinical Infectious Diseases 27, 1479-86.
36. Gacouin, A., Le Tulzo, Y., Lavoue, S., Camus, C., Hoff, J., Bassen, R. et al. (2002). Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Medicine 28, 686-91.
37. Byrd, R. P., Fields, C. L. & Roy, T. M. (1999). Prognostic factors in Legionella pneumonia. American Journal of Respiratory and Critical Care Medicine 159, 342.
38. Roig, J., Carreres, A. & Domingo, C. (1993). Treatment of Legionnaires' disease: current recommendations. Drugs 46, 63-79.
39. Edelstein, P. H. (1995). Antimicrobial chemotherapy for legionnaires' disease: a review. Clinical Infectious Diseases 21, Suppl. 3, S256-76.
40. Roig, J. & Domingo, C. (2001). Approach to severe legionellosis. In Severe Community-Acquired Pneumonia, 1st edn (Rello, J. & Leeper, K. V., Eds), pp. 41-56. Kluwer Academic Publishers, Boston, MA, USA.
41. Edelstein, P. H. (2002). Chemotherapy of Legionnaires' disease with macrolide or quinolone antimicrobial agents. In Legionella, 1st edn (Marre, R., Kwaik, Y. A., Bartlett, C., Cianciotto, N. P., Fields, B. S., Frosch, M. et al., Eds), pp. 183-8. ASM Press, Washington, DC, USA.
42. Garcia, M. T., Pelaz, C., Gimenez, M. J. & Aguilar, L. (2000). In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results. Antimicrobial Agents and Chemotherapy 44, 2176-8.
43. Kunishima, H., Takemura H., Yamamoto, H., Kanemitsu, K. & Shimada, J. (2000). Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549. Journal of Infection and Chemotherapy 6, 206-10.
44. Anderson, R., van Rensburg, C. E., Joonë, G. & Lukey, P. T. (1987). An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. Journal of Antimicrobial Chemotherapy 20, Suppl. B, 57-68.
45. Edelstein, P. H., Calarco, K. & Yasui, V. K. (1984). Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. American Review of Respiratory Diseases 130, 849-56.
46. Edelstein, P. H., Edelstein, M. A., Ren, J. J., Polzer, R. & Gladue, R. P. (1996). Activity of trovafloxacin (cp-99,219) against Legionella isolates: in-vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea-pig with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 40, 314-9.
47. Edelstein, P. H. & Edelstein, M. A. (1999). In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 43, 90-5.
48. Edelstein, P. H., Higa, F. & Edelstein, M. A. (2001). In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 45, 2685-90.
49. Edelstein, P. H., Shinzato, T. & Edelstein, M. A. (2001). BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Journal of Antimicrobial Chemotherapy 48, 667-75.
50. Fitzgeorge, R. B., Featherstone, A. S. & Baskerville, A. (1990). Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. Journal of Antimicrobial Chemotherapy 25, Suppl. A, 101-8.
51. Fitzgeorge, R. B., Lever, S. & Baskerville, A. (1993). A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 171-6.
52. Stout, J. E., Arnold, B. & Yu, V. L. (1998). Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. Journal of Antimicrobial Chemotherapy 41, 289-91.
53. Edelstein, P. H. & Edelstein, M. A. (2000). In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp. Diagnostic Microbiology and Infectious Disease 36, 49-52.
54. Edelstein, P. H. & Edelstein, M. A. (1991). In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrobial Agents and Chemotherapy 35, 180-1.
55. Edelstein, P. H., Edelstein, M. A. & Holzknecht, B. (1992). In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 36, 2387-91.
56. Edelstein, P. H., Edelstein, M. A., Lehr, K. H. & Ren, J. (1996). In-vitro activity of levofloxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Journal of Antimicrobial Chemotherapy 37, 117-26.
57. Edelstein, P. H., Edelstein, M. A., Weidenfeld, J. & Dorr, M. B. (1990). In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 34, 2122-7.
58. Friis-Møller, A., Chen, M., Fuursted, K., Christensen, S. B. & Kharazmi, A. (2002). In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Medica 68, 416-9.
59. Roig, J., Domingo, C. & Morera, J. (1994). Legionnaires' disease. Chest 105, 1817-25.
60. Edelstein, P. H., Shinzato, T., Doyle, E. & Edelstein, M. A. (2001). In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 45, 2204-9.
61. Baltch, A. L., Smith, R. P., Ritz, W. J., Franke, M. A. & Michelsen, P. B. (2000). Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila. Journal of Antimicrobial Chemotherapy 46, 51-5.
62. Nielsen, K., Bangsborg, J. M. & Høiby, N. (2000). Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin. Diagnostic Microbiology and Infectious Disease 36, 43-8.
63. Dournon, E., Mayaud, C., Wolff, M., Schlemmer, B., Samuel, D., Sollet, J. P. et al. (1990). Comparison of three antibiotic regimens in severe Legionnaires' disease. Journal of Antimicrobial Chemotherapy 26, Suppl. B, 129-39.
64. Paterson, D. L. & Singh, N. (1997). Interactions between tacrolimus and antimicrobial agents. Clinical Infectious Diseases 25, 1430-40.
65. Hubbard, R. B., Mathur, R. M. & MacFarlane, J. T. (1993) Severe community-acquired Legionella pneumonia: treatment, complications and outcome. Quarterly Journal of Medicine 86, 327-32.
66. Martin, S. J., Pendland, S. L., Chen, C., Schreckenberger, P. & Danziger, L. H. (1996). In vitro synergy of macrolide-quinolone combinations against 41 clinical isolates of Legionella. Antimicrobial Agents and Chemotherapy 40, 1419-21.
67. Shalit, I., Horev-Azaria, L., Fabian, I., Blau, H., Kariv, N., Shechtman, I. et al. (2002). Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide. Antimicrobial Agents and Chemotherapy 46, 2442-9.
68. Kuzman, I., Soldo, I., Schonwald, S. & Culig, J. (1995). Azithromycin for treatment of community-acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scandinavian Journal of Infectious Diseases 27, 503-5.
69. Morley, J. N., Smith, L. C., Baltch, A. L. & Smith, R. P. (1994). Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clinical Infectious Diseases 19, 1130-2.
70. Schindel, C., Siepmann, V., Han, S., Ullmann, A. J., Mayer, E., Fischer, T. et al. (2000). Persistent Legionella infection in a patient after bone marrow transplantation. Journal of Clinical Microbiology 38, 4294-5.
71. Matute, A. J., Schurink, C. A. M. & Hoepelman, I. M. (2000). Is a 5 day course of azithromycin enough for infections caused by Legionella pneumophila? Journal of Antimicrobial Chemotherapy 45, 930-1.
72. Dan, X. & Zhang, Z. (1999). Liver injury damage in sporadic Legionnaires' disease. Journal of Gastroenterology and Hepatology 14, Suppl. A, 411.
73. Larsson, A., Nilsson, B. & Eriksson, M. (1999). Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila infection. Thrombosis Research 96, 391-7.
74. Bemer, P., Leautez, S., Ninin, E., Jarraud, S., Raffi, F. & Drugeon, H. (2002). Legionella pneumophila arthritis. Use of medium specific for Mycobacteria for isolation of L. pneumophila in culture of articular fluid specimens. Clinical Infectious Diseases 35, E6-7.
75. Lettinga, K. D., Verbon, A., Nieuwkerk, P. T., Jonkers, R. E., Gersons, B. P., Prins, J. M. et al. (2002). Health-related quality of life and posttraumatic stress disorder among survivors of an outbreak of Legionnaires disease. Clinical Infectious Diseases 35, 11-7.
76. Meyer, R. D., Edelstein, P. H., Kirby, B. D., Louie, M. H., Mulligan, M. E., Morgenstein, A. A. et al. (1980). Legionnaires' disease: unusual clinical and laboratory features. Annals of Internal Medicine 93, 240-3.
77. Marrie, T., Haldane, D. & Bezanson, G. (1992). Nosocomial Legionnaires' disease: clinical and radiographic patterns. Canadian Journal of Infectious Diseases 3, 253-60.
78. Tan, M. J., Tan, J. S. & File, T. M. (2002). Legionnaires' disease with bacteremic coinfection. Clinical Infectious Diseases 35, 533-9.
79. Miyara, T., Tokashiki, K., Shimoji, T., Tamaki, K., Koide, M. & Saito, A. (2002). Rapidly expanding lung abscess caused by Legionella pneumophila in immunocompromised patients: a report of two cases. Internal Medicine 41, 133-7.
80. Lerolle, N., Zahar, J. R., Duboc, V., Tissier, F. & Rabbat, A. (2002). Pneumonia involving Legionella pneumophila and Listeria monocytogenes in an immunocompromised patient: an unusual coinfection. Respiration 69, 359-61.
81. Nichols, L., Strollo, D. C. & Kusne, S. (2002). Legionellosis in a lung transplant recipient obscured by cytomegalovirus infection and Clostridium difficile colitis. Transplant Infectious Disease 4, 41-5.
82. Dorman, S. E., Guide, S. V., Conville, P. S., De Carlo, E. S., Malech, H. L., Gallin, J. L. et al. (2002). Nocardia infection in chronic granulomatous disease. Clinical Infectious Diseases 35, 390-4.
83. Hayden, R. T., Uhl, J. R., Qian, X., Hopkins, M. K., Aubry, M. C. & Limper, A. H. (2001). Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridisation, direct fluorescence antigen detection, and culture. Journal of Clinical Microbiology 39, 2618-26.
84. van der Zee, A., Verbakel, H., de Jong, C., Pot, R., Bergmans, A. & Peeters, M. (2002). Novel PCR-probe assay for detection of and discrimination between Legionella pneumophila and other Legionella species in clinical samples. Journal of Clinical Microbiology 40, 1124-5.
85. Meduri, G. U. (1995). Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clinics in Chest Medicine 16, 61-93.
86. White, D. A., Wong, P. W. & Downey, R. (2000). The utility of open lung biopsy in patients with hematologic malignancies. American Journal of Respiratory and Critical Care Medicine 161, 723-9.
87. Ender, P. T. & Dolan, M. J. (1997). Pneumonia associated with near-drowning. Clinical Infectious Diseases 25, 896-907.
88. Lieberman, D., Lieberman, D., Shmarkov, O., Gelfer, Y., Ben-Yaakov, M., Lazarovich, Z. et al. (2002). Serological evidence of Legionella species infection in acute exacerbations of COPD. European Respiratory Journal 19, 392-7.
89. Roig, J., Soler, X., Domingo, C. & de Celis, G. (2002). Serological evidence of Legionella species infection in acute exacerbation of COPD. European Respiratory Journal 20, 504-6.
90. Boshuizen, H. C., Neppelenbrock, S. E., van Vilet, H., Schellekens, J. F. P., den Boer, J. W., Peeters, M. F. et al. (2001). Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. Journal of Infectious Diseases 184, 515-8.
91. Bouffandeau, B., Mofredj, A. & Blanc, S. (2001). Hemophagocytic syndrome in the critically ill. Intensive Care Medicine 27, 948.
92. Matsubara, S., Akashi, S., Naitoh, K., Nakahara, Y. & Hayashi, S. (1998). Severe Legionella micdadei pneumonia effectively treated with hemofiltration therapy. Nihon Kokyuki Gakkai Zasshi 36, 886-90.
93. Ichiba, S., Jenkins, D. R., Peek, G. J., Brennan, K. J., Killer, H. M., Sosnowski, A. et al. (1999). Severe acute respiratory failure due to Legionella pneumonia treated with extracorporeal membrane oxygenation. Clinical Infectious Diseases 28, 686-7.
94. Masuda, T., Ishikawa, Y., Akasaka, Y., Ishii, T., Tateda, K., Ishii, Y. et al. (2002). Follicular bronchiolitis associated with Legionella pneumophila infection. Pediatric Pathology and Molecular Medicine 21, 41-7.
95. Shinozawa, Y., Matsumoto, T., Uchida, K., Tsujimoto, S., Iwakura, Y. & Yamaguchi, K. (2002). Role of interferon-gamma in inflammatory responses in murine respiratory infection with Legionella pneumophila. Journal of Medical Microbiology 51, 225-30.
96. Deng, J. C., Tateda, K., Zeng, X. & Standiford, T. J. (2001). Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts. Infection and Immunity 69, 6382-90.
97. Vimercati, A., Greco, P., Bettocchi, S., Resta, L. & Selvaggi, L. (2000). Legionnaires' disease complicating pregnancy: a case report with intrauterine fetal demise. Journal of Perinatology Medicine 28, 147-50.
98. Franzin, L., Scolfaro, C., Cabodi, D., Valera, M. & Tobo, P. A. (2001). Legionella pneumophila pneumonia in a newborn after water birth: a new mode of transmission. Clinical Infectious Diseases 33, 103-4.
99. Einarson, A., Phillips, E., Mawji, F., D'Alimonte, D., Schick, B., Addis, A. et al. (1998). A prospective controlled multicentre study of clarithromycin in pregnancy. American Journal of Perinatology 15, 523-5.
100. Cooper, W. O., Ray, W. A. & Griffin, M. R. (2002). Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstetrics and Gynecology 100, 101-6.
101. Onody, C., Matsiota-Bernard, P. & Nauciel, C. (1997). Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila. Journal of Antimicrobial Chemotherapy 39, 815-6.
102. Tan, J. S., File, T. M., DiPersio, J. R., DiPersio, L. P., Hamor, R., Saravolatz, L. D. et al. (2001). Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. Clinical Infectious Diseases 32, 1562-6.
103. Rello, J., Bodí, M., Mariscal, D., Navarro, M., Diaz, E., Gallego, M. et al. (2003). Microbiologic testing and outcome of patients with severe community-acquired pneumonia. Chest 123, 174-80.
104. Sabria, M. & Yu, V. L. (2002). Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infectious Diseases 2, 368-73.
105. Yoon, W. S., Park, S. H., Park, Y. K., Park, S. C., Siin, J. I. & Kim, M. J. (2002). Comparison of responses elicited by immunization with a Legionella species common lipoprotein delivered as naked DNA or recombinant protein. DNA Cell Biology 21, 99-107.
106. Marrie, T. J., Bezanson, G., Haldane, D. J. & Burbridge, S. (1992). Colonization of the respiratory tract with Legionella pneumophila for 63 days before the onset of pneumonia. Journal of Infection 24, 81-6.
107. Pedro-Botet, M. L., Sabria, M., Sopena, N., Garcia Nunez, M., Morera, J. & Reynaga, E. (2002). Environmental legionellosis and oropharyngeal colonization Legionella in immunosuppressed patients. Infection Control and Hospital Epidemiology 23, 279-81.
108. Striz, I., Jaresova, M., Bohmova, R., Puchmajerova, J., Zazula, R., Korcakova, L. et al. (2002). Bronchial colonization of Legionella in patients before organ transplantation. American Journal of Respiratory and Critical Care Medicine 165, Suppl. A, 297.
109. Vereerstraeten, P., Stolear, J. C., Schoutens-Serruys, E., Maes, N., Thys, J. P., Liesnard, C. et al. (1986). Erythromycin prophylaxis for Legionnaires' disease in immunosuppressed patients in a contaminated hospital environment. Transplantation 41, 52-4.
110. Le Saux, N. M., Sekla, L., McLeod, J., Parker, S., Rush, D., Jeffery, J. R. et al. (1998). Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: a case-control and environmental study. Canadian Medical Association Journal 140, 1047-53.
111. Hummel, M. & Hetzer, K. R. (1999). Prophylactic and preemptive strategies for control of Legionnaires' disease in heart transplant recipients. A single center 10-years survey in a high-risk environment. Transplantation 67, S100.
112. Knirsch, C. A., Jakob, K., Schoonmaker, D., Kiehlbauch, J. A., Wong, S. J., Della-Latta, P. et al. (2000). An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control. American Journal of Medicine 108, 290-5.
113. Oren, I., Zuckerman, T., Avivi, I., Finkelstein, R., Yigla, M. & Rowe, J. M. (2002). Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transplant 30, 175-9.
114. Gray, G. C., Witucki, P. J., Gould, M. T., Bell, S. J., Hiliopoulos, K. M., McKeehan J. A. et al. (2001). Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. Clinical Infectious Diseases 33, 983-9.